Page last updated: 2024-08-23

bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Basal Ganglia Diseases

bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marsden, CD; Pycock, C; Tarsy, D1

Other Studies

1 other study(ies) available for bis(4-methyl-1-homopiperazinylthiocarbonyl)disulfide and Basal Ganglia Diseases

ArticleYear
Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum.
    Psychopharmacologia, 1975, Dec-31, Volume: 45, Issue:2

    Topics: Animals; Apomorphine; Basal Ganglia Diseases; Behavior; Biogenic Amines; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Chlorpromazine; Clozapine; Corpus Striatum; Dextroamphetamine; Diazepam; Dopamine; Haloperidol; Humans; Hydroxydopamines; Levodopa; Male; Metoclopramide; Mice; Motor Activity; Pentobarbital; Phenoxybenzamine; Pimozide; Promethazine; Stereotyped Behavior; Tranquilizing Agents

1975